跳至主要内容
临床试验/NCT06784570
NCT06784570已完成2 期

Impact of Perioperative Levosimendan on Patients Undergoing Cardiac Surgery With Low Ejection Fraction

Zagazig University1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2021年1月1日最近更新:
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
240
试验地点
1
主要终点
death through day 30,

研究概览

简要总结

to compar levosemindan to other cardiac intropic medications that strengthen the heart in diffrent common adult heart surgery with patients with low ejection fraction(weak heart)

详细描述

in this study show the effect of levosemindan use during coronary artery surgery ,heart valve surgery and combined coronary and valve surgery in comparison to other traditional medications with patients with low ejection fraction(weak heart)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Valve surgery
  • CABG surgery,
  • combined surgery
  • all patients Ejection Fraction less than 35 ٪ -

排除标准

  • Patients age ≤ 20-70 < years
  • Aortic and redo surgery
  • any patients with Ejection Fraction more than 35 ٪ -

研究组 & 干预措施

traditional

Active Comparator

this group of patients will recieve traditional intropic drugs

干预措施: adrenaline,noreadrenaline,dopamine and doputamine (Drug)

levosemindan

Experimental

this group of patients will recieve levosemindan

干预措施: levosemindan (Drug)

结局指标

主要结局

death through day 30,

时间窗: 1 month (no scale for measurement as death may occured due to multible causes that be difficult to be identified and measured )

death occured either intraoperative , ICU, ward or after discharge to home within month of the day of the surgery

Renal-replacement therapy

时间窗: 1 month

included haemodialysis, peritoneal dialysis, or continuous Veno venous haemodialysis(indicated when serum creatinine above 2.0 mg/dl or an increase of 50% above baseline value)

Perioperative myocardial infarction

时间窗: 5 days

defined as a creatine kinase MB level of more than 100 ng per millilitre or a level that was more than 10 times the upper limit of the normal range specified at the local laboratory, regardless of changes on the electrocardiogram, or a creatine kinase MB level that was more than 50 ng per millilitre or a level that was more than 5 times the upper limit of the normal range with new Q waves that were more than 30 msec in duration in two contiguous leads or new left bundle-branch block

Intra Aortic Ballon Pumb insertion

时间窗: 5 days(no scale for measurement )

it consisidered to be one of the ventricular assissted device that need to be inserted in post cardiac surgery shocked patiients that not respond heamdynamically to highest doses of cardiac intropes

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Mohamed Ibrahim Mohamed El Anwar

assis professor

Zagazig University

研究点 (1)

Loading locations...

相似试验